Ben Scheidt is part of the investment team at Redstone, and is responsible for the MA.Ventures and BTG funds. Recent highlights of investments include Lykon with MA.Ventures and Surve Mobility with BTG. With a passion for healthcare, he has an active role in the development of the HealthTech practice within Redstone. Ben joined Redstone after gaining experience in strategy consulting and the pharmaceutical industry. He enjoys Japanese cuisine, Golf and Chess, holds a Masters degree from ESCP Europe and completed an executive program at Stanford University.
News | 03.09.2021 Read more
News | 23.08.2021 Read more